SAN DIEGO, Oct. 8 SGX Pharmaceuticals, Inc.(Nasdaq: SGXP) will be presenting at the BIO InvestorForum on October 11,2007, at 1:00 p.m. Pacific Daylight Time. Mike Grey, president and chiefexecutive officer of SGX Pharmaceuticals, will provide an overview of theCompany's oncology pipeline. The conference is being held October 9th throughthe 11th at the Palace Hotel in San Francisco.
A live webcast of the presentation will be available under the investorrelations section of the Company's website at http://www.sgxpharma.com.Replays of the presentation will be available for 90 days following the event.Please connect to the Company's website several minutes prior to the start ofthe broadcast to ensure adequate time for any software download that may benecessary.
About SGX Pharmaceuticals
SGX Pharmaceuticals is a biotechnology company focused on the discovery,development and commercialization of innovative cancer therapeutics. The SGXoncology pipeline includes drug candidates from its enabling, proprietary FAST(TM) drug discovery platform, such as next generation BCR-ABL inhibitors, METtyrosine kinase inhibitors, including SGX523, and potent JAK2 inhibitors.More information on the pipeline and drug discovery platform can be found athttp://www.sgxpharma.com and in the Company's various filings with theSecurities and Exchange Commission.
SOURCE SGX Pharmaceuticals, Inc.